
Opinion|Videos|April 3, 2025
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
Advertisement
Episodes in this series

Advertisement
Related to this article

After a run of 2026 oral SERD approvals, Erica L. Mayer, MD, MPH, discusses ESR1 testing and a possible adjuvant role for giredestrant.

Lisa Carter-Bawa, PhD, MPH, APRN, describes how AI could flag patients eligible for lung screening and why nurses must stay the human in the loop.

An ONS nursing practice leader shares takeaways from EONS19 at ESMO 2026, from workforce sustainability to new therapies and subcutaneous care.

Erica L. Mayer, MD, MPH, explains what the all-oral giredestrant plus everolimus regimen asks of patients and oncology nurses between clinic visits.

JoAnne Page, RN, a breast cancer survivor, shares what oncology nurses can do for care partners of patients with bladder cancer.

Lisa Carter-Bawa, PhD, MPH, APRN, explains how blame keeps patients from lung cancer care and how nurses can counter that stigma in the community.

At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
New ASH Myelofibrosis Guidelines: Key Points for Nurses and APPs
2
Workplace Violence in Oncology: What Nurses Need to Know
3
Oral SERDs: What Giredestrant Signals for Nurses
4
Oral Giredestrant Shifts Care Home: How Nurses Can Support Adherence
5

